Bamco Inc Genmab A/S Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

A detailed history of Bamco Inc transactions in Genmab A/S stock. As of the latest transaction made, Bamco Inc holds 72,374 shares of GMAB stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,374

Previous 87,153 16.96%

Holding current value

$1.49 Million

Previous $2.19 Million 19.45%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $352,331 - $420,905	-14,779 Reduced 16.96%	72,374 $1.76 Million
Q2 2024 Aug 14, 2024	BUY	$25.13 - $30.27 $374,989 - $451,688	14,922 Added 20.66%	87,153 $2.19 Million
Q1 2024 May 15, 2024	SELL	$26.43 - $32.77 $1.76 Million - $2.19 Million	-66,714 Reduced 48.01%	72,231 $2.16 Million
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $279,400 - $354,400	-10,000 Reduced 6.71%	138,945 $4.42 Million
Q3 2023 Nov 14, 2023	SELL	$35.27 - $42.24 $529,050 - $633,600	-15,000 Reduced 9.15%	148,945 $5.25 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $187,000 - $214,700	-5,000 Reduced 2.96%	163,945 $6.23 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $1.6 Million - $1.98 Million	-45,814 Reduced 21.33%	168,945 $6.38 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $745,830 - $1.04 Million	22,066 Added 11.45%	214,759 $9.1 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $466,496 - $5.53 Million	-14,800 Reduced 7.13%	192,693 $6.19 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $1.29 Million - $1.85 Million	-48,000 Reduced 18.79%	207,493 $6.74 Million
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $70,380 - $90,232	-2,274 Reduced 0.88%	255,493 $9.24 Million
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $190,111 - $249,736	-5,300 Reduced 2.01%	257,767 $10.2 Million
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $62,324 - $73,080	-1,500 Reduced 0.57%	263,067 $11.5 Million
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $825,288 - $1.12 Million	25,100 Added 10.48%	264,567 $10.8 Million
Q1 2021 May 19, 2021	BUY	$30.92 - $44.4 $2.91 Million - $4.18 Million	94,193 Added 64.84%	239,467 $7.86 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $4.89 Million - $5.92 Million	145,274 New	145,274 $5.91 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account